Work

HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications

Year: 2025

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2025.09.1633

Authors: Fábio Cardoso Borges, Luigi Lim, Maria Manuel Teixeira, Francesco Pignatti, Madeline Pe, Caroline Voltz, Denis Lacombe, Carla Torre, Isabelle Huys

Institutions: European Organisation for Research and Treatment of Cancer, European Medicines Agency, University of Lisbon, KU Leuven

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417480602

Cites:

Cited by:

Related to: 10